In CD133-positive glioma stem cells (GSCs), the miR-145/OCT4/SOX2 axis confers radio-chemo resistance, while inhibition of this axis increases the sensitivity to temozolomide (TMZ) and radiation, following a decreased expression of ABCG2, MDR1 and Bcl2 [113]. This evidence concerns the gene SOX2 and central nervous system cancer.